Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Mar 1;290(Pt 2):419–426. doi: 10.1042/bj2900419

Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

M A Soos 1, C E Field 1, K Siddle 1
PMCID: PMC1132290  PMID: 8452530

Abstract

Hybrid insulin/insulin-like growth factor-I (IGF-I) receptors have previously been described in human placenta, but it has not been possible to study their properties in the presence of classical insulin receptors and type I IGF receptors. To facilitate the purification of hybrids, we produced an anti-peptide monoclonal antibody IGFR 1-2, directed against the C-terminal peptide of the type I IGF receptor beta-subunit. The antibody bound native human and rat type I IGF receptors, and reacted specifically with the beta-subunit on immunoblots. Solubilized placental microsomal membranes were depleted of classical type I IGF receptors by incubation with an immobilized monoclonal antibody IGFR 24-55, which reacts well with type I receptors but very poorly with hybrid receptors. Residual hybrid receptors were then isolated by incubation with immobilized antibody IGFR 1-2, and recovered by elution with excess of synthetic peptide antigen. Binding properties of hybrids were compared with those of immuno-affinity-purified insulin receptors and type I IGF receptors, by using the radioligands 125I-IGF-I and 125I-insulin. Hybrids bound approx. 20 times as much 125I-IGF-I as 125I-insulin at tracer concentrations (approx. 0.1 nM). The binding of 125I-insulin, but not 125I-IGF-I, to hybrids increased after treatment with dithiothreitol to reduce disulphide bonds between the alpha-subunits. Hybrids behaved very similarly to type I receptors with respect to the inhibition of 125I-IGF-I binding by unlabelled IGF-I and insulin. By contrast, the affinity of hybrids for insulin was approx. 10-fold lower than that of classical insulin receptors, as assessed by inhibition of 125I-insulin binding by unlabelled hormone. It is concluded that the properties of insulin receptors, but not IGF receptors, are markedly affected by assembly as hybrid compared with classical structures, and that hybrids are more likely to be responsive to IGF-I than insulin under physiological conditions.

Full text

PDF
419

Images in this article

421Figure 1
on p.421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamo M., Roberts C. T., Jr, LeRoith D. How distinct are the insulin and insulin-like growth factor I signalling systems? Biofactors. 1992 Jan;3(3):151–157. [PubMed] [Google Scholar]
  2. Bassiri R. M., Utiger R. D. The preparation and specificity of antibody to thyrotropin releasing hormone. Endocrinology. 1972 Mar;90(3):722–727. doi: 10.1210/endo-90-3-722. [DOI] [PubMed] [Google Scholar]
  3. Briand J. P., Muller S., Van Regenmortel M. H. Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods. 1985 Apr 8;78(1):59–69. doi: 10.1016/0022-1759(85)90329-1. [DOI] [PubMed] [Google Scholar]
  4. Burant C. F., Treutelaar M. K., Allen K. D., Sens D. A., Buse M. G. Comparison of insulin and insulin-like growth factor I receptors from rat skeletal muscle and L-6 myocytes. Biochem Biophys Res Commun. 1987 Aug 31;147(1):100–107. doi: 10.1016/s0006-291x(87)80092-x. [DOI] [PubMed] [Google Scholar]
  5. Böni-Schnetzler M., Scott W., Waugh S. M., DiBella E., Pilch P. F. The insulin receptor. Structural basis for high affinity ligand binding. J Biol Chem. 1987 Jun 15;262(17):8395–8401. [PubMed] [Google Scholar]
  6. Chang K. J., Jacobs S., Cuatrecasas P. Quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones. Biochim Biophys Acta. 1975 Oct 6;406(2):294–303. doi: 10.1016/0005-2736(75)90011-5. [DOI] [PubMed] [Google Scholar]
  7. Cunningham B. C., Ultsch M., De Vos A. M., Mulkerrin M. G., Clauser K. R., Wells J. A. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science. 1991 Nov 8;254(5033):821–825. doi: 10.1126/science.1948064. [DOI] [PubMed] [Google Scholar]
  8. Czech M. P. The nature and regulation of the insulin receptor: structure and function. Annu Rev Physiol. 1985;47:357–381. doi: 10.1146/annurev.ph.47.030185.002041. [DOI] [PubMed] [Google Scholar]
  9. DeMeyts P., Bainco A. R., Roth J. Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem. 1976 Apr 10;251(7):1877–1888. [PubMed] [Google Scholar]
  10. Fabry M., Schaefer E., Ellis L., Kojro E., Fahrenholz F., Brandenburg D. Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem. 1992 May 5;267(13):8950–8956. [PubMed] [Google Scholar]
  11. Feltz S. M., Swanson M. L., Wemmie J. A., Pessin J. E. Functional properties of an isolated alpha beta heterodimeric human placenta insulin-like growth factor 1 receptor complex. Biochemistry. 1988 May 3;27(9):3234–3242. doi: 10.1021/bi00409a017. [DOI] [PubMed] [Google Scholar]
  12. Fujita-Yamaguchi Y., Choi S., Sakamoto Y., Itakura K. Purification of insulin receptor with full binding activity. J Biol Chem. 1983 Apr 25;258(8):5045–5049. [PubMed] [Google Scholar]
  13. Galfrè G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. doi: 10.1016/0076-6879(81)73054-4. [DOI] [PubMed] [Google Scholar]
  14. Ganderton R. H., Stanley K. K., Field C. E., Coghlan M. P., Soos M. A., Siddle K. A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem J. 1992 Nov 15;288(Pt 1):195–205. doi: 10.1042/bj2880195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hales C. N., Woodhead J. S. Labeled antibodies and their use in the immunoradiometric assay. Methods Enzymol. 1980;70(A):334–355. doi: 10.1016/s0076-6879(80)70063-0. [DOI] [PubMed] [Google Scholar]
  16. Heidaran M. A., Pierce J. H., Yu J. C., Lombardi D., Artrip J. E., Fleming T. P., Thomason A., Aaronson S. A. Role of alpha beta receptor heterodimer formation in beta platelet-derived growth factor (PDGF) receptor activation by PDGF-AB. J Biol Chem. 1991 Oct 25;266(30):20232–20237. [PubMed] [Google Scholar]
  17. Hintz R. L., Thorsson A. V., Enberg G., Hall K. IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides. Biochem Biophys Res Commun. 1984 Feb 14;118(3):774–782. doi: 10.1016/0006-291x(84)91462-1. [DOI] [PubMed] [Google Scholar]
  18. Humbel R. E. Insulin-like growth factors I and II. Eur J Biochem. 1990 Jul 5;190(3):445–462. doi: 10.1111/j.1432-1033.1990.tb15595.x. [DOI] [PubMed] [Google Scholar]
  19. Izumi T., White M. F., Kadowaki T., Takaku F., Akanuma Y., Kasuga M. Insulin-like growth factor I rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. J Biol Chem. 1987 Jan 25;262(3):1282–1287. [PubMed] [Google Scholar]
  20. Jacobs S., Chang K-J, Cuatrecasas P. Estimation of hormone receptor affinity by competitive displacement of labeled ligand: effect of concentration of receptor and of labeled ligand. Biochem Biophys Res Commun. 1975 Sep 16;66(2):687–692. doi: 10.1016/0006-291x(75)90564-1. [DOI] [PubMed] [Google Scholar]
  21. Jonas H. A., Cox A. J., Harrison L. C. Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta. Biochem J. 1989 Jan 1;257(1):101–107. doi: 10.1042/bj2570101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jonas H. A., Cox A. J. Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9). Biochem J. 1990 Mar 15;266(3):737–742. doi: 10.1042/bj2660737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jonas H. A., Eckardt G. S., Clark S. Expression of atypical and classical insulin receptors in Chinese hamster ovary cells transfected with cloned cDNA for the human insulin receptor. Endocrinology. 1990 Sep;127(3):1301–1309. doi: 10.1210/endo-127-3-1301. [DOI] [PubMed] [Google Scholar]
  24. Kjeldsen T., Andersen A. S., Wiberg F. C., Rasmussen J. S., Schäffer L., Balschmidt P., Møller K. B., Møller N. P. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4404–4408. doi: 10.1073/pnas.88.10.4404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lammers R., Gray A., Schlessinger J., Ullrich A. Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 1989 May;8(5):1369–1375. doi: 10.1002/j.1460-2075.1989.tb03517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LeBon T. R., Jacobs S., Cuatrecasas P., Kathuria S., Fujita-Yamaguchi Y. Purification of insulin-like growth factor I receptor from human placental membranes. J Biol Chem. 1986 Jun 15;261(17):7685–7689. [PubMed] [Google Scholar]
  27. Maly P., Lüthi C. Purification of the type I insulin-like growth factor receptor from human placenta. Biochem Biophys Res Commun. 1986 Jun 13;137(2):695–701. doi: 10.1016/0006-291x(86)91134-4. [DOI] [PubMed] [Google Scholar]
  28. McClain D. A., Maegawa H., Lee J., Dull T. J., Ulrich A., Olefsky J. M. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem. 1987 Oct 25;262(30):14663–14671. [PubMed] [Google Scholar]
  29. Milazzo G., Yip C. C., Maddux B. A., Vigneri R., Goldfine I. D. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. J Clin Invest. 1992 Mar;89(3):899–908. doi: 10.1172/JCI115670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Misra P., Hintz R. L., Rosenfeld R. G. Structural and immunological characterization of insulin-like growth factor II binding to IM-9 cells. J Clin Endocrinol Metab. 1986 Dec;63(6):1400–1405. doi: 10.1210/jcem-63-6-1400. [DOI] [PubMed] [Google Scholar]
  31. Moxham C. P., Duronio V., Jacobs S. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem. 1989 Aug 5;264(22):13238–13244. [PubMed] [Google Scholar]
  32. Moxham C. P., Jacobs S. Insulin/IGF-I receptor hybrids: a mechanism for increasing receptor diversity. J Cell Biochem. 1992 Feb;48(2):136–140. doi: 10.1002/jcb.240480205. [DOI] [PubMed] [Google Scholar]
  33. Olefsky J. M. The insulin receptor. A multifunctional protein. Diabetes. 1990 Sep;39(9):1009–1016. doi: 10.2337/diab.39.9.1009. [DOI] [PubMed] [Google Scholar]
  34. Pang D. T., Shafer J. A. Evidence that insulin receptor from human placenta has a high affinity for only one molecule of insulin. J Biol Chem. 1984 Jul 10;259(13):8589–8596. [PubMed] [Google Scholar]
  35. Pang D. T., Shafer J. A. Stoichiometry for the binding of insulin to insulin receptors in adipocyte membranes. J Biol Chem. 1983 Feb 25;258(4):2514–2518. [PubMed] [Google Scholar]
  36. Quian X. L., Decker S. J., Greene M. I. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1330–1334. doi: 10.1073/pnas.89.4.1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rechler M. M., Nissley S. P. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol. 1985;47:425–442. doi: 10.1146/annurev.ph.47.030185.002233. [DOI] [PubMed] [Google Scholar]
  38. Samokyszyn V. M., Miller D. M., Reif D. W., Aust S. D. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem. 1989 Jan 5;264(1):21–26. [PubMed] [Google Scholar]
  39. Schumacher R., Mosthaf L., Schlessinger J., Brandenburg D., Ullrich A. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem. 1991 Oct 15;266(29):19288–19295. [PubMed] [Google Scholar]
  40. Seifert R. A., Hart C. E., Phillips P. E., Forstrom J. W., Ross R., Murray M. J., Bowen-Pope D. F. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem. 1989 May 25;264(15):8771–8778. [PubMed] [Google Scholar]
  41. Shimizu M., Webster C., Morgan D. O., Blau H. M., Roth R. A. Insulin and insulinlike growth factor receptors and responses in cultured human muscle cells. Am J Physiol. 1986 Nov;251(5 Pt 1):E611–E615. doi: 10.1152/ajpendo.1986.251.5.E611. [DOI] [PubMed] [Google Scholar]
  42. Soos M. A., Field C. E., Lammers R., Ullrich A., Zhang B., Roth R. A., Andersen A. S., Kjeldsen T., Siddle K. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem. 1992 Jun 25;267(18):12955–12963. [PubMed] [Google Scholar]
  43. Soos M. A., Siddle K., Baron M. D., Heward J. M., Luzio J. P., Bellatin J., Lennox E. S. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J. 1986 Apr 1;235(1):199–208. doi: 10.1042/bj2350199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Soos M. A., Siddle K. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J. 1989 Oct 15;263(2):553–563. doi: 10.1042/bj2630553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Soos M. A., Whittaker J., Lammers R., Ullrich A., Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 1990 Sep 1;270(2):383–390. doi: 10.1042/bj2700383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Soos M., Taylor S. J., Gard T., Siddle K. A rapid, sensitive two-site immunometric assay for TSH using monoclonal antibodies: investigation of factors affecting optimisation. J Immunol Methods. 1984 Oct 26;73(2):237–249. doi: 10.1016/0022-1759(84)90398-3. [DOI] [PubMed] [Google Scholar]
  47. Stanker L. H., Vanderlaan M., Juarez-Salinas H. One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatography. J Immunol Methods. 1985 Jan 21;76(1):157–169. doi: 10.1016/0022-1759(85)90488-0. [DOI] [PubMed] [Google Scholar]
  48. Steele-Perkins G., Turner J., Edman J. C., Hari J., Pierce S. B., Stover C., Rutter W. J., Roth R. A. Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem. 1988 Aug 15;263(23):11486–11492. [PubMed] [Google Scholar]
  49. Sun X. J., Rothenberg P., Kahn C. R., Backer J. M., Araki E., Wilden P. A., Cahill D. A., Goldstein B. J., White M. F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 1991 Jul 4;352(6330):73–77. doi: 10.1038/352073a0. [DOI] [PubMed] [Google Scholar]
  50. Sweet L. J., Morrison B. D., Pessin J. E. Isolation of functional alpha beta heterodimers from the purified human placental alpha 2 beta 2 heterotetrameric insulin receptor complex. A structural basis for insulin binding heterogeneity. J Biol Chem. 1987 May 25;262(15):6939–6942. [PubMed] [Google Scholar]
  51. Takata Y., Webster N. J., Olefsky J. M. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. J Biol Chem. 1991 May 15;266(14):9135–9139. [PubMed] [Google Scholar]
  52. Tollefsen S. E., Thompson K. The structural basis for insulin-like growth factor I receptor high affinity binding. J Biol Chem. 1988 Nov 5;263(31):16267–16273. [PubMed] [Google Scholar]
  53. Treadway J. L., Morrison B. D., Soos M. A., Siddle K., Olefsky J., Ullrich A., McClain D. A., Pessin J. E. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):214–218. doi: 10.1073/pnas.88.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ullrich A., Bell J. R., Chen E. Y., Herrera R., Petruzzelli L. M., Dull T. J., Gray A., Coussens L., Liao Y. C., Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. 1985 Feb 28-Mar 6Nature. 313(6005):756–761. doi: 10.1038/313756a0. [DOI] [PubMed] [Google Scholar]
  55. Ullrich A., Gray A., Tam A. W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986 Oct;5(10):2503–2512. doi: 10.1002/j.1460-2075.1986.tb04528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wada T., Qian X. L., Greene M. I. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell. 1990 Jun 29;61(7):1339–1347. doi: 10.1016/0092-8674(90)90697-d. [DOI] [PubMed] [Google Scholar]
  57. Waldbillig R. J., Chader G. J. Anomalous insulin-binding activity in the bovine neural retina: a possible mechanism for regulation of receptor binding specificity. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1105–1112. doi: 10.1016/s0006-291x(88)80480-7. [DOI] [PubMed] [Google Scholar]
  58. Wedekind F., Baer-Pontzen K., Bala-Mohan S., Choli D., Zahn H., Brandenburg D. Hormone binding site of the insulin receptor: analysis using photoaffinity-mediated avidin complexing. Biol Chem Hoppe Seyler. 1989 Mar;370(3):251–258. doi: 10.1515/bchm3.1989.370.1.251. [DOI] [PubMed] [Google Scholar]
  59. Weiland M., Bahr F., Höhne M., Schürmann A., Ziehm D., Joost H. G. The signaling potential of the receptors for insulin and insulin-like growth factor I (IGF-I) in 3T3-L1 adipocytes: comparison of glucose transport activity, induction of oncogene c-fos, glucose transporter mRNA, and DNA-synthesis. J Cell Physiol. 1991 Dec;149(3):428–435. doi: 10.1002/jcp.1041490311. [DOI] [PubMed] [Google Scholar]
  60. White M. F., Maron R., Kahn C. R. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature. 1985 Nov 14;318(6042):183–186. doi: 10.1038/318183a0. [DOI] [PubMed] [Google Scholar]
  61. Whittaker J., Okamoto A. K., Thys R., Bell G. I., Steiner D. F., Hofmann C. A. High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5237–5241. doi: 10.1073/pnas.84.15.5237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yip C. C., Hsu H., Patel R. G., Hawley D. M., Maddux B. A., Goldfine I. D. Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Biochem Biophys Res Commun. 1988 Nov 30;157(1):321–329. doi: 10.1016/s0006-291x(88)80050-0. [DOI] [PubMed] [Google Scholar]
  63. Zick Y. The insulin receptor: structure and function. Crit Rev Biochem Mol Biol. 1989;24(3):217–269. doi: 10.3109/10409238909082554. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES